Evidence map›Paper›PMID 35028717›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Attitude towards hereditary cancer risk management among women with cancer in Taiwan.

Su-Ying Fang, Ling-Ling Hsieh, Chen-Fang Hung, Fei-Hung Hung, Hung-Pin Peng, An-Suei Yang, Yong Alison Wang

Abstract read
PubMed Publisher
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.4field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Su-Ying FangDepartment of Nursing, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Ling-Ling HsiehDepartment of Internal Medicine, Koo Foundation Sun-Yat Sen Cancer Center, Taipei, Taiwan.
Chen-Fang HungDepartment of Research, Koo Foundation Sun-Yat Sen Cancer Center, Taipei, Taiwan.
Fei-Hung HungGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Hung-Pin PengGenomics Research Center, Academia Sinica, Taipei, Taiwan.
An-Suei YangGenomics Research Center, Academia Sinica, Taipei, Taiwan.
Yong Alison WangDepartment of Internal Medicine, Koo Foundation Sun-Yat Sen Cancer Center, Taipei, Taiwan. wang@kfsyscc.org.ORCID http://orcid.org/0000-0001-7361-348X
Genomics Research Center, Academia Sinica · TWKoo Foundation Sun Yat-Sen Cancer Center · TWNational Cheng Kung University · TWNational Yang Ming Chiao Tung University · TW

Funding

Academia Sinica Short-term Visiting Program for Domestic ScholarsHealth Promotion Administration, Ministry of Health and Welfare MOHW110-TDU-B-212-144021
6 · The paper itself

Abstract

backgroundRisk management intentions prior to genetic counseling predict risk management uptake following genetic testing. Limited studies examined the attitude and understanding towards genetic counseling/testing in underserved countries. The purposes of this study were to explore knowledge and attitude towards genetic counseling, testing, and risk management for breast and ovarian cancer, and to understand the factors influencing risk management intentions in women with cancer in Taiwan.

methodsCross-sectional with correlational design was used in this study. Participants were enrolled for genetic testing based on clinical criteria suspected of having hereditary cancer. Survey was conducted using a standardized questionnaire including (1) demographics and personal/family history of cancer; (2) prior experience or consideration of genetic testing and reasons for not considering; (3) perception and attitude towards genetic counseling; and (4) intentions for risk management with a hypothetical BRCA1 mutation status. Multinomial logistic regression was used to analyze the predictors of participants' intentions for cancer risk management strategies.

resultsA total of 430 women with cancer were analyzed in which 51.6% had family history of cancer in first-degree relatives. Only 30.7% had considered genetic testing and 28.4% had known about genetic counseling prior to the study. When prompted with the services of genetic counseling, the attitude towards genetic counseling was fairly positive (score of 19.8 ± 2.9 out of 25). Given hypothetical BRCA1 mutation status, enhanced breast cancer screening with annual breast MRI was much more accepted than cancer risk reducing interventions. More positive attitude towards genetic counseling (each score point increase) was associated with higher odds of intention for breast MRI (OR 1.20, 95% CI 1.09-1.32) and preventive tamoxifen (OR 1.11, 95% CI 1.02-1.22). Having considered genetic testing prior to the study was associated with higher odds of intention for all four risk management strategies: breast MRI (OR 2.99, 95% CI 1.46-6.11), preventive tamoxifen (OR 1.79, 95% CI 1.00-3.17), risk-reducing mastectomy (OR 2.24, 95% CI 1.13-4.42), and risk-reducing salpingo-oophorectomy (OR 2.69, 95% CI 1.27-6.93).

conclusionKnowledge of genetic testing and positive attitude towards genetic counseling were associated with increased willingness to consider cancer risk management strategies for hereditary breast and ovarian cancer syndrome. Given the limited knowledge on genetic testing and counseling in the studied population, increasing public awareness of these services may increase adoption of the risk management strategies.

Indexed as

Breast NeoplasmsOvarian NeoplasmsCross-Sectional StudiesFemaleGenes, BRCA1Genes, BRCA2Genetic Predisposition to DiseaseGenetic TestingHumansLogistic ModelsMastectomyMutationRisk ManagementTaiwanGenetic counselingGenetic testingHereditary cancerRisk management

Identifiers

PMID35028717
OpenAlexW4205449333

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.